Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Full Disclosure Trading -- Ignore unavailable to you. Want to Upgrade?

To: Sam Citron who wrote (10389)	11/1/2005 3:16:22 PM
From: The Ox	Read Replies (1) \| Respond to of 13403

OT Sam, Are you referencing this? On May 31, 2005, several members of the management team of Cascade Microtech, Inc., (“Cascade Microtech”), Eric Strid, its Chairman and Chief Executive Officer and a director, Reed Gleason, its Vice President, Advanced Development and a director, Bruce McFadden, its VP and General Manager, Pyramid Probe Division, John Pence, its VP and General Manager, Engineering Products Division, and F. Paul Carlson, a director, established stock trading plans in accordance with Rule 10b5-1 of the General Rules and Regulations promulgated by the Securities and Exchange Commission under the Securities Exchange Act of 1934, as amended, to provide for pre-determined sales of a portion of their Cascade Microtech common stock, subject to certain contingencies. Under the Rule 10b5-1 plans, Mr. Strid will sell up to a maximum of 250,000 shares over a period of up to 15 months, which represents approximately 14% of Mr. Strid’s current direct and indirect holdings of Cascade Microtech common stock and options to purchase common stock and less than 2% of the currently outstanding common stock of Cascade Microtech at June 30, 2005; Mr. Gleason will sell up to a maximum of 250,000 shares over a period of up to 15 months, which represents approximately 15% of Mr. Gleason’s current holdings of Cascade Microtech common stock and options to purchase common stock and less than 2% of the currently outstanding common stock of Cascade Microtech; Mr. McFadden will sell up to a maximum of 107,000 shares over a period of up to 15 months, which represents approximately 38% of Mr. McFadden’s current holdings of Cascade Microtech common stock and options to purchase common stock and less than 1% of the currently outstanding common stock of Cascade Microtech; Mr. Pence will sell up to a maximum of 64,654 shares over a period of up to 15 months, which represents approximately 38% of Mr. Pence’s current holdings of Cascade Microtech common stock and options to purchase common stock and less than 1% of the currently outstanding common stock of Cascade Microtech; and Mr. Carlson will sell up to a maximum of 25,000 shares over a period of up to 15 months, which represents approximately 16% of Mr. Carlson’s current holdings of Cascade Microtech common stock and options to purchase common stock and less than 1% of the currently outstanding common stock of Cascade Microtech. The Rule 10b5-1 plans identified above were adopted in May 2005 during an open trading window for company employees under the Company’s Statement of Policy Regarding Insider Trading. The first sales of shares of Cascade Microtech common stock under these Rule 10b5-1 plans will not occur for at least 90 days following when the plans were adopted, which is expected to occur in early September, 2005. Rule 10b5-1 permits the implementation of written, prearranged stock trading plans by insiders when the insiders are not in possession of material non-public information, and allows the insiders to trade on a regular basis, regardless of any subsequent material non-public information they receive. Such plans allow insiders to diversify their holdings and to minimize the market impact of stock sales by spreading them out over time. Transactions under the plans will be disclosed publicly through Form 144 and Form 4 filings with the Securities and Exchange Commission.